Ramesh Ramanathan, M.D.
Ramesh K. Ramanathan, MD, specializes in developing new treatments for colon and pancreatic cancers. Dr Ramanathan joined the Translational Genomics Research Institute (TGen) as Deputy Director of the Translational Research Division and as Senior Investigator, with a joint appointment at the Scottsdale Clinical Research Institute (SCRI) in March 2007. In addition, Dr Ramanathan is a Clinical Professor of Medicine, University of Arizona, College of Medicine, Phoenix, AZ. Prior to this appointment, Dr Ramanathan served as Associate Professor of Medicine, Division of Hematology/ Oncology and Director of the GI Oncology Program at the University of Pittsburgh Cancer Institute.

Donald Richards, M.D., Ph.D.
Donald A Richards, MD, PhD received his bachelors degree in Biochemistry from Occidental College, a cum laude with departmental honors, in 1976. He attended the Baylor College of Medicine, receiving his Ph.D. in 1982 and his M.D. at the University of Texas Health Science Center in 1983. He completed his residency in Internal Medicine at Bexar County Teaching Hospital in San Antonio, Texas followed by Fellowship in Medical Oncology at the University of Texas Health Science Center.

Paul Ritch, M.D.
Dr. Ritch received his medical degree from Tufts University School of Medicine in Boston, Massachusetts and joined the Medical College of Wisconsin in 1980. Dr. Ritch actively participates in clinical trials and investigational studies evaluating new chemotherapy drugs and biological agents in cancer therapy.

Peter J. Rosen, M.D.
Peter J. Rosen, MD, formerly Professor of Clinical Medicine and Director, Solid Tumor Division, at University of California, Los Angeles, is now an Emeritus Professor at UCLA. Dr. Rosen received his medical degree from The University of Southern California. His postgraduate training included an internship and residency at Johns Hopkins University and fellowships in medical oncology at National Institutes of Health, National Cancer Institute, and in hematology at The University of Southern California School of Medicine. He is board certified in internal medicine with subspecialty certification in hematology and oncology. Dr. Rosen�s research interests include non-Hodgkin�s lymphoma, B-cell chronic lymphocytic leukemia, sarcomas and a variety of other malignancies. In addition to contributing book chapters and abstracts, he has published articles in New England Journal of Medicine, Journal of Clinical Oncology, Blood and other journals. He is a member of several professional organizations including the American Society of Clinical Oncology, American Society of Hematology, and American College of Physicians. He is currently the Medical Director of Tower Cancer Research Foundation and engaged in performing clinical trials for a multimember practice in Beverly Hills, California.